What to Tell Your Patients: A Critical Review of the JAMA Cardiology Meta-Analysis “Associations of Omega-3 Fatty Acid Supplement use with Cardiovascular Disease Risks” | Zendy

Alex Vasquez | Zendy; Elizabeth Sutherland | Zendy

Open Access

What to Tell Your Patients: A Critical Review of the JAMA Cardiology Meta-Analysis “Associations of Omega-3 Fatty Acid Supplement use with Cardiovascular Disease Risks”

Author(s) -

Alex Vasquez,

Elizabeth Sutherland

Publication year - 2019

Publication title -

journal of restorative medicine

Language(s) - English

Resource type - Journals

eISSN - 2330-2941

pISSN - 2165-7971

DOI - 10.14200/jrm.2019.0102

Subject(s) - meta analysis , medicine , disease , intervention (counseling) , coronary heart disease , cardiology , bioavailability , intensive care medicine , pharmacology , psychiatry

Authors of a meta-analysis recently published in JAMA Cardiology concluded that omega-3 fatty acids have no significant association with fatal or nonfatal coronary heart disease or any major vascular events. This critical review examines participant profile, intervention dosage, bioavailability of intervention, and duration of therapy for the cited trials and determines that the conclusion of the meta-analysis is tentative at best.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research